Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia

Maryam Ebadi, Justin Wasko, Daniel J. Weisdorf, Peter M. Gordon, Armin Rashidi

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia'. Together they form a unique fingerprint.